💊 Sulfonylureas for Diabetes: How They Work, Types, and Side Effects

Sulfonylureas are one of the oldest classes of oral diabetes medications, and they are still widely used today because they are effective and inexpensive. However, they come with a notable risk of hypoglycemia (low blood sugar) and weight gain, which means they must be used carefully. Dr. Ravi Sishir Reddy explains how sulfonylureas work, which drugs are in this class, and what you need to know to take them safely.

1. What Are Sulfonylureas?

Sulfonylureas are a group of oral medications that stimulate the pancreas to release more insulin. They have been used since the 1950s and remain a common second‑line therapy (or first‑line in some settings) for Type 2 diabetes. They bind to a specific receptor (SUR1) on the beta cells of the pancreas, triggering insulin secretion regardless of the blood glucose level. This makes them highly effective at lowering blood sugar, but also increases the risk of hypoglycemia.

Sulfonylureas are often used when metformin alone is not enough to achieve blood sugar targets, or in patients who cannot tolerate metformin. Because they rely on a functioning pancreas, they are not effective in people with Type 1 diabetes or those with very advanced beta‑cell failure.

2. Common Sulfonylureas Prescribed

• Glimepiride (Amaryl): A second‑generation sulfonylurea, usually taken once daily. It has a relatively lower risk of prolonged hypoglycemia compared to some older agents.
• Glibenclamide (Glyburide): Potent and long‑acting; used once or twice daily. It has a higher risk of hypoglycemia, especially in the elderly, and is generally less preferred in modern guidelines.
• Gliclazide (Diamicron): Also a second‑generation agent, considered to have a lower risk of hypoglycemia than glibenclamide and may have some antioxidant properties.
• Glipizide (Glucotrol): Short‑acting, taken twice or three times daily; requires meal‑time dosing but may have slightly lower hypoglycemia risk than longer‑acting agents.

3. How Do Sulfonylureas Lower Blood Sugar?

Sulfonylureas work by closing ATP‑sensitive potassium channels on the surface of pancreatic beta cells. This depolarises the cell, allowing calcium to enter, which triggers the release of insulin‑containing granules. The key point is that this mechanism is independent of the blood glucose level. Unlike the body's natural insulin secretion, which is finely tuned to glucose concentration, sulfonylurea‑induced insulin release happens even when blood sugar is normal or low — which is why hypoglycemia is a significant risk.

4. Why Are Sulfonylureas Still Prescribed?

• Potent glucose‑lowering effect: They can reduce HbA1c by 1‑2%.
• Low cost: Most sulfonylureas are available as inexpensive generics, making them accessible in low‑resource settings.
• Oral administration: No injections required.
• Long history of use: Decades of clinical experience provide a clear picture of their safety profile.

However, modern guidelines increasingly favour medications with cardiovascular and kidney benefits (like SGLT2 inhibitors and GLP‑1 agonists) over sulfonylureas when cost is not a barrier.

5. Side Effects and Important Risks

• Hypoglycemia (low blood sugar): This is the most serious risk. Because sulfonylureas stimulate insulin release regardless of glucose levels, they can cause blood sugar to drop too low — especially if a meal is skipped, delayed, or contains insufficient carbohydrates. Symptoms include sweating, shakiness, confusion, and in severe cases, coma. Hypoglycemia is more common with long‑acting sulfonylureas like glibenclamide and in elderly patients.
• Weight gain: Sulfonylureas typically cause a weight gain of 2‑5 kg, likely due to increased insulin levels promoting fat storage and the need to eat to prevent or treat hypoglycemia.
• Secondary failure: Over time (typically years), many patients lose responsiveness to sulfonylureas as beta‑cell function declines, requiring additional medications or insulin.
• Cardiovascular concerns: Older sulfonylureas (especially first‑generation agents no longer in use) were associated with increased cardiovascular risk. Modern sulfonylureas like glimepiride and gliclazide appear to be safer, but the evidence of benefit seen with newer agents is lacking.
• Photosensitivity and skin rashes: Rare side effects.

6. Who Should Not Take Sulfonylureas?

• Type 1 diabetes or LADA: Sulfonylureas are ineffective and can accelerate beta‑cell destruction.
• Severe liver or kidney impairment: Reduced clearance increases the risk of prolonged hypoglycemia.
• Pregnancy and breastfeeding: Insulin is the preferred treatment; sulfonylureas are generally avoided.
• Elderly patients at high risk of falls: Hypoglycemia can cause dizziness and falls, leading to fractures.
• Known sulfa allergy: Sulfonylureas contain a sulfonamide group, and cross‑reactivity with sulfa antibiotics is possible (though rare).

7. Practical Tips for Taking a Sulfonylurea

• Take it with or before meals: This aligns the insulin release with food intake and reduces the risk of hypoglycemia. Always eat a meal after taking your sulfonylurea — never take it on an empty stomach and skip the meal.
• Monitor your blood sugar regularly: Especially when starting, changing doses, or if you feel symptoms of low sugar.
• Recognise hypoglycemia: Know the signs (shakiness, sweating, hunger, confusion) and always carry fast‑acting sugar (glucose tablets, a small juice, or sweet) with you.
• Avoid alcohol on an empty stomach: Alcohol can mask the symptoms of hypoglycemia and worsen the drop.
• Inform your doctor of any kidney or liver changes: Your dose may need adjustment.
• Do not stop abruptly: If you need to discontinue, your doctor will provide an alternative treatment plan.